Spectrum Pharmaceuticals CEO Joseph Turgeon's 2021 pay jumps 110% to $7.8M
Spectrum Pharmaceuticals reports 2021 executive compensation
By ExecPay News
Published: April 27, 2022
Spectrum Pharmaceuticals reported fiscal year 2021 executive compensation information on April 27, 2022.
In 2021, five executives at Spectrum Pharmaceuticals received on average a compensation package of $3.5M, a 42% increase compared to previous year.
Average pay of disclosed executives at Spectrum Pharmaceuticals
Joseph W. Turgeon, Chief Executive Officer, received $7.8M in total, which increased by 110% compared to 2020.
For fiscal year 2021, the median employee pay was $158,327 at Spectrum Pharmaceuticals. Therefore, the ratio of Joseph W. Turgeon's pay to the median employee pay was 49 to one.
Thomas J. Riga, Chief Executive Officer, received a compensation package of $2.8M, which increased by 11% compared to previous year. 46% of the compensation package, or $1.3M, was in option awards.
Kurt A. Gustafson, Chief Financial Officer, earned $2.4M in 2021, a 16% increase compared to previous year.
Francois J. Lebel, Chief Medical Officer, received $2.4M in 2021, which increases by 7% compared to 2020.
Keith M. McGahan, Chief Legal Officer, earned $2.3M in 2021, a 19% increase compared to previous year.
Related executives
Thomas Riga
Spectrum Pharmaceuticals
Chief Executive Officer
Kurt Gustafson
Spectrum Pharmaceuticals
Chief Financial Officer
Francois Lebel
Spectrum Pharmaceuticals
Chief Medical Officer
Keith McGahan
Spectrum Pharmaceuticals
Chief Legal Officer
Joseph Turgeon
Spectrum Pharmaceuticals
Chief Executive Officer
You may also like
Source: SEC filing on April 27, 2022.